Aurisco Pharmaceutical Co., Ltd. (605116.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 19.30

From 52W high−43.42%

Volume2.85M

Market capCNY 7.91B

P/E (TTM)17.6x

P/S (TTM)4.8x

Div yield1.72%

Key dataSep 18, 2026

Open

CNY 19.30

From 52W high

−43.42%

Volume

2.85M

Market cap

CNY 7.91B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

11.6x

P/E (TTM)

17.6x

RSI (14)

50.8

MomentumView details →

1D Return

−2.36%

YTD Return

−21.12%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

17.6x

EV/EBITDA

11.6x

EV/Sales

4.4x

P/S (TTM)

4.8x

P/B (TTM)

3.1x

ProfitabilityView details →

Gross Margin

57.96%

Net Margin

23.37%

EBITDA Margin

38.12%

ROE (TTM)

14.48%

ROA (TTM)

9.26%

Asset Turnover

0.40x

GrowthView details →

Revenue YoY

+9.25%

EPS YoY

+0.33%

FCF YoY

+155.29%

Revenue CAGR 3Y

+18.97%

EPS CAGR 3Y

+29.14%

EBITDA YoY

—

MomentumView details →

1D Return

−2.36%

YTD Return

−21.12%

1Y Return

−12.87%

RSI (14)

50.8

vs 50D SMA

−0.75%

vs 200D SMA

−15.02%

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

4.22x

Quick Ratio

2.84x

Div Yield

1.72%

Div Rate

CNY 0.34

Div Growth 1Y

+17.24%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.68B

Net Income (TTM)

393.72M

Op. CF (TTM)

484.02M

Latest newsMore news →

Aoruite announced its first-half 2026 results: net profit attributable to shareholders was 159 million yuan, down 32.42% year-on-year.24d ago

Aurit's wholly-owned subsidiary Yangzhou Aurit received a drug supplementary application approval notice from China's National Medical Products Administration for a new 1mg specification of estradiol tablets/estradiol-dydrogesterone tablets composite packaging.28d ago

Similar companies

键凯科技688356.SH 技源集团603262.SH 老百姓603883.SH Definium Therapeutics, Inc.DFTX 西藏药业600211.SH Beijing Tong Ren Tang Chinese Medicine Company Limited03613.HK Find similar companies →

Latest newsMore news →

Aoruite announced its first-half 2026 results: net profit attributable to shareholders was 159 million yuan, down 32.42% year-on-year.24d ago Aurit's wholly-owned subsidiary Yangzhou Aurit received a drug supplementary application approval notice from China's National Medical Products Administration for a new 1mg specification of estradiol tablets/estradiol-dydrogesterone tablets composite packaging.28d ago